MARY WEBB: Open Payments
NPI 1700132792 · VIENNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,769 in 75 payments from 17 companies in 2025. Trend: 2023 $568 · 2024 $1,178 · 2025 $1,769
Food & beverage: $1,710Education: $59
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $273 |
| GENZYME CORPORATION | 5 | $230 |
| Regeneron Healthcare Solutions, Inc. | 5 | $182 |
| PFIZER INC. | 9 | $174 |
| CSL Behring | 7 | $172 |
| GlaxoSmithKline, LLC. | 10 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $141 |
| LEO Pharma Inc. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Amgen Inc. | 3 | $67 |
Products named: DUPIXENT, AIRSUPRA, Hizentra, CUVITRU, TEZSPIRE, NUCALA, CUTAQUIG, ADBRY.
Industry payments across GA — which companies pay providers there.
